Facebook
Twitter
Telegram
Report an ErrorIovance Biotherapeutics Financial Statements 2011-2024 | IOVA
Annual Financial Statements Iovance Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
4.11 M | 1.15 M | 2.93 M | 6.42 M | 2.79 B | 845 M | 969 M | 381 M | 266 M | 196 M | 63.8 M | 8.78 M | 79.7 M |
Shares |
235 K | 159 K | 153 K | 138 K | 124 M | 97.3 M | 65.2 M | 55.3 M | 44.4 M | 25 M | 9.76 M | 799 K | 759 K |
Historical Prices |
17.5 | 7.2 | 19.1 | 46.4 | 27.7 | 8.85 | 8 | 6.95 | 7.72 | 7.87 | 10.5 | 22 | 100 |
Net Income |
-444 M | -396 M | -342 M | -260 M | -198 M | -124 M | -92.1 M | -52.9 M | -27.7 M | -12 M | -25.4 M | -3.31 M | -25.7 M |
Revenue |
1.19 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
10.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-461 M | -399 M | -343 M | -262 M | -207 M | -128 M | -92.9 M | -53.6 M | -27.9 M | -12 M | -22.6 M | -8.13 M | -21.2 M |
Interest Expense |
- | - | - | - | - | - | - | - | 200 K | -5.66 K | 445 K | 1.92 M | 152 K |
EBITDA |
-449 M | -390 M | -340 M | -261 M | -206 M | -127 M | -91.9 M | -52.7 M | -26.9 M | -12 M | -22.6 M | -8.13 M | -21.1 M |
Operating Expenses |
- | - | - | 262 M | 207 M | 128 M | 92.9 M | 53.6 M | 27.9 M | 12 M | 22.6 M | 8.13 M | 21.1 M |
General and Administrative Expenses |
107 M | 104 M | 83.7 M | 60.2 M | 40.8 M | 28.4 M | 21.3 M | 25.6 M | 12.4 M | 9.34 M | 4.66 M | 6.48 M | - |
All numbers in USD currency
Quarterly Income Statement Iovance Biotherapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
266 M | 256 M | 246 M | 224 M | 214 M | 188 M | 158 M | 157 M | 157 M | 157 M | 156 M | 154 K | 147 K | 147 K | 146 K | 133 K | 127 K | 126 K | 124 K | 124 K | 123 K | 119 K | 95.1 K | 90.2 K | 84.4 K | 72.8 K | 63.3 K | 62.5 K | 62.3 K | 62.1 K | 59.1 K | 51.1 K | 48.5 K | 47.9 K | 47.3 M | 45.1 M | 37.7 M | 28.3 K | 26.6 M | 24.1 M | 20.8 M | 20 M | 14.2 M | 819 K | 819 K | 819 K | 783 K | 783 K | 781 K | 78 M | 78.3 M | 78 M | 78 M |
Net Income |
-113 M | - | -114 M | -107 M | -107 M | - | -99.6 M | -99.3 M | -91.6 M | - | -86.1 M | -81.4 M | -75.4 M | -68.4 M | -58.6 M | -63 M | -69.6 M | -63.6 M | -49.5 M | -47.6 M | -37 M | -32.6 M | -33.8 M | -30.7 M | -26.5 M | -25.9 M | -22.1 M | -23.4 M | -20.7 M | -15.7 M | -68.2 M | -11.6 M | -6.88 M | -8.36 M | -7.64 M | -6.37 M | -5.3 M | -4.65 M | -3.01 M | -2.11 M | -2.26 M | - | -9.41 M | -3.43 M | -1.05 M | - | -674 K | -327 K | -5.77 M | - | -5.82 M | -11 M | -564 K |
Revenue |
715 K | - | 469 K | 238 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
7.26 M | - | 4.34 M | 2.05 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-118 M | - | -118 M | -110 M | -111 M | - | -100 M | -99.7 M | -91.7 M | - | -86.2 M | -81.4 M | -75.6 M | - | -59 M | -63.6 M | -70.8 M | - | -51.6 M | -50.2 M | -40 M | - | -35.1 M | -31.4 M | -26.9 M | - | -22.3 M | -23.6 M | -20.9 M | - | -19 M | -11.7 M | -7.01 M | - | -7.64 M | -6.44 M | -5.3 M | - | -2.8 M | -2.11 M | -2.26 M | - | -9.41 M | -1.03 M | -705 K | - | -1.63 M | -1.65 M | -3.14 M | - | -5.81 M | -10.6 M | -658 K |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 221 K | 164 K | 126 K | - | 8 K | 73 K | - | - | -4.19 K | - | - | - | - | 104 K | 342 K | - | 127 K | 111 K | 88.5 K | - | 31.6 K | -399 K | - |
EBITDA |
-115 M | - | -115 M | -107 M | -108 M | - | -97.9 M | -97.5 M | -89.9 M | - | -84.5 M | -81.1 M | -75.2 M | - | -58.1 M | -63.1 M | -70.6 M | - | -50.7 M | -49.6 M | -39.7 M | - | -34.4 M | -30.9 M | -26.6 M | - | -21.6 M | -23.1 M | -20.7 M | - | -18.3 M | -11.2 M | -6.74 M | - | -6.95 M | -6.02 M | -5.11 M | - | -2.78 M | -2.09 M | -2.24 M | - | -9.4 M | -1.03 M | -703 K | - | -1.62 M | -1.64 M | -3.13 M | - | -5.76 M | -10.5 M | -640 K |
Operating Expenses |
- | - | - | - | 111 M | - | 100 M | - | 91.7 M | - | 86.2 M | 81.4 M | 75.6 M | - | 59 M | 63.6 M | 70.8 M | - | 51.6 M | 50.2 M | 40 M | - | 35.1 M | 31.4 M | 26.9 M | - | 22.3 M | 23.6 M | 20.9 M | - | 19 M | 11.7 M | 7.01 M | - | 7.64 M | 6.44 M | 5.3 M | - | 2.8 M | 2.11 M | 2.26 M | - | 9.41 M | 1.03 M | 705 K | - | 1.63 M | 1.65 M | 3.14 M | - | 5.81 M | 10.6 M | 658 K |
General and Administrative Expenses |
31.4 M | - | 27 M | 21.9 M | 28.1 M | - | 27.9 M | 26.3 M | 23.4 M | - | 20.9 M | 19.3 M | 19.6 M | - | 15.9 M | 14.4 M | 13.9 M | - | 10 M | 10.9 M | 9.08 M | - | 7.11 M | 6.83 M | 6.96 M | - | 5.66 M | 4.93 M | 5.29 M | - | 10.5 M | 7.26 M | 2.82 M | - | 2.68 M | 2.38 M | 2.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency